Abstract:4but it was only in the 1970s that safe single-dose oral drugs, such as oxamniquine and praziquantel, were introduced for human therapy. 5 Progress in the war against schistosomiasis is badly needed, because the number of infected people is not decreasing and the available treatments are insufficient. Although socioeconomic progress has eliminated schistosomiasis from large areas of the world, the development of irrigation resources and population movements have spread the disease to previously non-endemic territories. Thus 200 million people are infected and 650 million are at risk. In 2002 there were 280 000 deaths from schistosomiasis. 6 No new drugs are being developed, despite the pending threat of drug resistance, and it is unlikely that an effective vaccine will become available during the next decade. 7 The infective agent is a waterborne larva (the cercaria) that penetrates intact human skin in contaminated freshwater. After penetration, the cercaria undergoes complex transformation and migration through the host tissues, until it settles in the mesenteric veins (Schistosoma mansoni and S japonicum) or in the perivesical veins (S haematobium). At this stage, the adult worms are sexually differentiated and can mate and produce eggs. About half the eggs traverse the intestinal or vesical wall and thus escape to the external environment via faeces or urine, hatch in contact with freshwater, and release a swimming larva (miracidium) that infects the intermediate host, an aquatic snail. The cercariae that emerge a month later from the snail are ready to infect humans and start the cycle again. Eggs retained in the human body are responsible for the clinical features of the disease. They accumulate in the liver or in the tissues of the urinary tract, where they elicit an immune reaction characterised by the formation of granulomas. One of the most fascinating—and harmful— features of schistosomes is their ability to survive and produce eggs for many years in the human body, surprisingly evading any immune rejection. Depending on the species, a schistosome pair can produce one egg every 1–10 min; hence the number of eggs and granulomas that accumulate in human tissues over the years is astounding. The pathological process is slow, and the infected person may stay free of serious symptoms for many years and perhaps for life, despite anaemia. However, a small and unpredictable proportion of individuals (generally less than 10%) develop serious problems that range from bloody diarrhoea to portal hypertension and liver cirrhosis, or from haematuria to hydronephrosis. Ectopic localisation of eggs (eg, in the nervous system, genital tract, skin) can cause various symptoms, whereas, for S mansoni, the most common cause of death is the rupture of oesophageal varices after portal hypertension. Bladder cancer associated with S haematobium infection also contributes to the death toll. Two recent papers in Nature Genetics provide new impetus in practical schistosomiasis research. Sergio Verjovski-Almeida

[A Case-Control Study on Risk Factors for Advanced Schistosomiasis Japonica].

[A Case-Control Study on the Risk Factors of Cerebral Schistosomiasis Japonica].

[Re-Understanding of Liver Cirrhosis Induced by Schistosomiasis Japonica].

Morbidity in Schistosomiasis Japonica in Relation to Intensity of Infection

Prevalence and incidence of advanced schistosomiasis and risk factors for case fatality in Hunan Province, China

Clinical analysis on 62 cases of cerebral schistosomiasis

[Burden of disease in schistosomiasis japonica III household socioeconomic determinants of chronic schistosomiasis]

Risk Factors Associated with Reinfection of Schistosoma Japonicum

The Dynamics of Hepatic Fibrosis Related to Schistosomiasis and Its Risk Factors in a Cohort of China

Studies on risk factors for liver fibrosis of schistosomiasis japonica]

Assessment of knowledge, attitude and practices and analysis on risk factor regarding schistosomiasis among fishermen and boatmen in Dongting Lake Basin, P.R. China

The Seroepidemiological Survey on the Relationship Between HBV and Schistosome Infection in an Endemic Area of Schisomiasis Japonica

Risk factors for schistosomiasis

Schistosoma Japonicum: Modern Tools for an Ancient Disease

Effect of hepatocyte damage in hepatic fibrogenesis of patients infected with Schistosoma japonicum

Lipid Metabolism Regulate the Inflammatory Microenvironment in the Hepatic Fibrosis Induced by Schistosoma Japonicum Infection in China: A Genotype-Phenotype Association Study

[Investigation on Prevalence and Risk Factors of HIV/AIDS and Schistosoma Japonicum, Ascaris Lumbricoides and Trichuris Trichiura Infections in a Rural Community of Southwestern China].

Impact of historical disease conditions on mortality and life expectancy in patients with advanced schistosomiasis in Hunan Province, China

Reviews and advances in diagnostic research on Schistosoma japonicum

A Recent Advance in the Diagnosis, Treatment, and Vaccine Development for Human Schistosomiasis

Schistosoma japonicum infection associated with membranous nephropathy: a case report